» Articles » PMID: 12098066

T Cell Infiltration and Chemokine Expression: Relevance to the Disease Localization in Murine Graft-versus-host Disease

Overview
Specialty General Surgery
Date 2002 Jul 5
PMID 12098066
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Acute graft-versus-host disease (GVHD) involves mainly skin, liver and intestines. Other organs such as heart, muscle and central nervous system are seldom affected, although their parenchymal cells also express alloantigens, such as MHC class I antigens. The mechanism of this selective involvement of distinct organs in acute GVHD is not well understood. We postulated that it might be related to the selective migration of activated alloreactive T cells. Indeed, T cell infiltration, revealed by examination of serial samples using flow cytometry and immunohistology, occurred early and continuously in the target organs such as the liver, but not in a non-target organ, the heart, in a murine acute GVHD model. Since T cell migration is largely controlled by the expression of chemokine and chemokine receptors, we investigated the chemokine spectrum in target/non-target organs of mice with acute GVHD. We found that in the spleen and liver MIP-1alpha, MIP-2 and Mig were the predominant chemokines expressed. In another target organ, the skin, MIP-1alpha, MIP-2, MCP-1 and MCP-3 were all highly expressed. In a non-target organ of acute GVHD, the heart, the predominant chemokines expressed were MCP-1 and MCP-3. This distinct pattern of chemokine expression in these organs may contribute to the preferential recruitment of inflammatory cells into the liver and skin, but not into the heart, in acute GVHD.

Citing Articles

Special immune-related adverse events and subsequent photodynamic therapy in tislelizumab treatment for esophageal cancer: a case report.

Li L, Bian L, Kou N, Yuan Y, Zou H Front Immunol. 2024; 15:1497259.

PMID: 39654898 PMC: 11625816. DOI: 10.3389/fimmu.2024.1497259.


Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD.

Olivieri A, Mancini G Cells. 2024; 13(18.

PMID: 39329708 PMC: 11431085. DOI: 10.3390/cells13181524.


The effect of ADAMTS13 on graft-versus-host disease.

Li D, Cho M, Gonzalez-Delgado R, Liang X, Dong J, Cruz M J Cell Mol Med. 2024; 28(13):e18457.

PMID: 38963011 PMC: 11222974. DOI: 10.1111/jcmm.18457.


Separation of GVL from GVHD -location, location, location.

Teshima T, Hashimoto D Front Immunol. 2023; 14:1296663.

PMID: 38116007 PMC: 10728488. DOI: 10.3389/fimmu.2023.1296663.


Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study.

Maximova N, Nistico D, Riccio G, Maestro A, Barbi E, Kotnik B Cancers (Basel). 2023; 15(14).

PMID: 37509268 PMC: 10376946. DOI: 10.3390/cancers15143605.